Average Co-Inventor Count = 5.89
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Celgene Corporation (12 from 549 patents)
2. Signal Pharmaceuticals, Inc. (6 from 169 patents)
18 patents:
1. 12029738 - Antiproliferative compounds and methods of use thereof
2. 11733233 - Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
3. 11419861 - Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
4. 11241423 - Antiproliferative compounds and methods of use thereof
5. 11185543 - Antiproliferative compounds and methods of use thereof
6. 10830762 - Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
7. 10668057 - Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
8. 10357489 - Antiproliferative compounds and methods of use thereof
9. 10092555 - Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
10. 9968596 - Antiproliferative compounds and methods of use thereof
11. 9808451 - Antiproliferative compounds and methods of use thereof
12. 9783505 - Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
13. 9556126 - Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
14. 9499514 - Antiproliferative compounds and methods of use thereof
15. 9156798 - Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith